Ran-Lansoprazole 15mg. 30mg Capsule
PDF Leaflet Revision Date: 10 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of gastric and duodenal ulcers, reflux oesophagitis, and mild functional dyspepsia.
Dosage (summary)
30 mg once daily for gastric/duodenal ulcers; 15 mg once daily for maintenance.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Warfarin
- Methotrexate
- Digoxin
- Atazanavir
- Clopidogrel
Contraindications
- Hypersensitivity to lansoprazole
- Severe liver impairment
- Pregnancy
- Lactation
Common side effects
- Diarrhoea
- Nausea
- Headache
- Dizziness
- Skin rash
Counselling Points
- Take before meals
- Monitor magnesium levels during prolonged use
- Avoid alcohol and CNS depressants
Serious warnings
- Acute interstitial nephritis
- Risk of Clostridium difficile associated diarrhoea
- Risk of bone fractures
Important Disclaimer
The Ran-Lansoprazole 15mg. 30mg Capsule professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
